Surgical Management of Secondary Hyperparathyroidism in Uremia
- 1 June 1999
- journal article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 317 (6) , 390-397
- https://doi.org/10.1016/s0002-9629(15)40552-x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Surgical Treatment of Secondary Hyperparathyroidism: Indication, Operative Management and Results1Published by S. Karger AG ,2015
- Secondary hyperparathyroidism in renal failure: The trade-off hypothesis revisitedAmerican Journal of Kidney Diseases, 1995
- 1-Alpha-Hydroxyvitamin D3 Derivatives in the Treatment of Renal Bone Diseases: Justification and Optimal Modalities of AdministrationNephron, 1995
- Parathyroidectomy for patients with renal hyperparathyroidism refractory to calcitriol pulse therapyJournal of Bone and Mineral Metabolism, 1994
- Recent progress in management of secondary hyperparathyroidism of chronic renal failureCurrent Opinion in Nephrology and Hypertension, 1993
- The ‘Oral 1,25-Dihydroxyvitamin D3 Pulse Therapy’ in Hemodialysis Patients with Severe Secondary HyperparathyroidismNephron, 1991
- Regression of Parathyroid Hyperplasia by Calcitriol-Pulse Therapy in Patients on Long-Term DialysisNew England Journal of Medicine, 1990
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989
- Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.Journal of Clinical Investigation, 1989
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984